Emergent BioSolutions Inc (EBS)

60.29 -1.33  -2.16% NYSE May 10, 15:12 USD
View Full Chart
Price Chart
View All EBS News

News

View All Events

Events

Date Type Description
07/30/2021 00:00 Earnings Results Q2 2021 Earnings Results
07/30/2021 17:00 Earnings Calls Q2 2021 Earnings Call
04/29/2021 00:00 Earnings Results Q1 2021 Earnings Results
04/29/2021 17:00 EDT Earnings Calls Q1 2021 Earnings Call
02/18/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/18/2021 17:00 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 00:00 Earnings Results Q3 2020 Earnings Results
11/05/2020 17:00 EST Earnings Calls Q3 2020 Earnings Call
07/30/2020 17:00 EDT Earnings Calls Q2 2020 Earnings Call
07/30/2020 00:00 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products.
  • URL: http://www.emergentbiosolutions.com
  • Investor Relations URL: http://investors.emergentbiosolutions.com/phoenix.zhtml?c=202582&p=irol-IRHome
  • HQ State/Province: Maryland
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Jul. 30, 2021
  • Last Earnings Release: Apr. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
SBIO ALPS Medical Breakthroughs ETF 2.53%
FEDX Emles Federal Contractors ETF 2.16%
RBF892 RBC U.S. Mid-Cap Value Equity Fund Adv 2.06%
PJP Invesco Dynamic Pharmaceuticals ETF 2.00%
HSCSX Homestead Small Company Stock 1.83%
GERM ETFMG Treatments Testing and Adv ETF 1.70%
CSCCX Calvert Small-Cap C 1.58%
NBGAX Neuberger Berman Genesis Adv 1.58%
MNSQX Invesco Main Street Small Cap R5 1.32%
JSMD Janus Henderson Small/Md Cp Gr Alpha ETF 1.12%
GSROX Goldman Sachs Small Cap Gr Insghts R 0.89%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.